Industry observers believe that Y chromosome sequencing services — until now the domain of advanced genetic genealogists and academics — could become more popular.
Kailos has launched a model where consumers can order testing without a doctor's prescription, but would need a doctor to view and interprest results.
The company made the move after several media outlets falsely reported that Ancestry had divulged the identify of a donor without a police warrant.
While it may be dominating the market in terms of sales, some industry observers believe that AncestryDNA has work to do before it can challenge the quality of services offered by its rivals.
For the first time in the consumer genomics industry, AncestryDNA will provide customers with a list of probable ancestors based solely on their microarray data.
Scheller discussed with GenomeWeb why he joined 23andMe after leaving Genentech and his plans for the new therapeutics division.
The consumer genomics firm has created a therapeutics group headed up by former Genentech executive Richard Scheller.
The value of consumer genomics services is increasing as customers seek to discover new cousins and adoptees track down their biological birth parents.
Genentech and 23andMe aim to advance Parkinson's drug research by sequencing the largest number of people to date.
Consumer genomics companies have seen their databases swell with hundreds of thousands of new samples, introduced diverse offerings, and adjusted to new competitors.
23andMe and Airbnb have partnered to offer "heritage travel," according to Venture Beat.
China may include regulations protecting genes and embryos in its update of its civil code, Nature News reports.
In Nature this week: exome sequence analysis of individuals with type 2 diabetes, genomic prediction of maize yield across environments, and more.
NPR reports on efforts to engineer bacteriophages to destroy antibiotic-resistance bacteria.